胜利者的号角：看郝新2010Science雄文的春秋笔法# WaterWorld - 未名水世界
w*l
1 楼
Urologist Arrested for Attacks on Chinese Whistleblowers
by Hao Xin on 23 September 2010, 11:00 AM
BEIJING—The police bureau here announced Tuesday evening that they have
detained the suspected mastermind behind assaults on China's science
misconduct watchdog Fang Shimin (aka Fang Zhouzi) and journalist Fang
Xuanchang. (The two Fangs are not related.)
Earlier on 21 September, police detained Xiao Chuanguo, chief urology
surgeon at the Tongji Hospital affiliated with Huazhong University of
Science and Technology (HUST) in Wuhan, after Xiao returned from a trip to
Argentina. According to a Beijing police report published online, Xiao
believed that the Fangs' muckraking investigation of his academic
achievements resulted in his failure to be elected a member of the Chinese
Academy of Sciences (CAS). Chinese media have reported that, according to a
police briefing, Xiao paid about $15,000 to a distant relative, who
allegedly arranged the assaults on Fang Xuanchang in June and Fang Zhouzi in
August. Police took the relative and two accomplices into custody earlier
this month.
The bone of contention between Xiao and the Fangs is a surgical procedure
Xiao developed that he claimed can help patients with spinal cord injury and
spina bifida to restore some control over bladder and bowl movements. After
seeing material supporting Xiao's nomination as member of CAS in 2005, Fang
Zhouzi asserted on his Web site, New Threads, that Xiao's procedure was not
nearly as internationally famous as Xiao claimed and alleged that Xiao
exploited the Chinese public's inability to access information in English to
inflate his achievement. Xiao sued Fang for libel in a Wuhan court and won
in 2006, but attempts to sue Fang in Beijing courts failed.
Last December, while working for the Chinese biweekly Science News, Fang
Xuanchang edited a series of investigative reports on Xiao's procedure,
which has been performed on thousands of Chinese patients, according to Xiao
. Before the Ministry of Health in May 2009 issued regulations banning the
clinical application of unproven and controversial medical procedures such
as stem cell therapy, some Chinese hospitals peddled experimental procedures
to make more money. It's not clear whether Xiao's procedure falls in the
banned category, but no clinical trials have been conducted in China to
prove its efficacy. Many prospective patients were enticed by the touted 85%
success rate. Since publication of the investigative reports, however, "the
number of patients seeking treatment has fallen sharply," says Jia Hepeng,
editor-in-chief of Science News.
The procedure also caught the attention of Kenneth Peters, director of
urology research at the William Beaumont Hospital in Royal Oak, Michigan,
who launched a phase II clinical trial at his hospital (see also an
Associated Press report). Trial results have not been published. Peters also
obtained two grants from the National Institute of Health to study the
safety and efficacy of the procedure for treating spina bifida patients.
According to a description in his grant proposal, preliminary results show
that seven out of nine patients who received the treatment have shown
improvements. Peters did not respond to an e-mail request for comment.
Xiao could not be reached for comment. His employer, HUST, yesterday issued
an online statement that said the university was shocked by the police
investigation into Xiao's alleged crime of intentional injury to others. The
statement says that the university will follow the case closely and take
appropriate action once the judicial system renders its verdict.
Follow ScienceInsider on Facebook and Twitter
by Hao Xin on 23 September 2010, 11:00 AM
BEIJING—The police bureau here announced Tuesday evening that they have
detained the suspected mastermind behind assaults on China's science
misconduct watchdog Fang Shimin (aka Fang Zhouzi) and journalist Fang
Xuanchang. (The two Fangs are not related.)
Earlier on 21 September, police detained Xiao Chuanguo, chief urology
surgeon at the Tongji Hospital affiliated with Huazhong University of
Science and Technology (HUST) in Wuhan, after Xiao returned from a trip to
Argentina. According to a Beijing police report published online, Xiao
believed that the Fangs' muckraking investigation of his academic
achievements resulted in his failure to be elected a member of the Chinese
Academy of Sciences (CAS). Chinese media have reported that, according to a
police briefing, Xiao paid about $15,000 to a distant relative, who
allegedly arranged the assaults on Fang Xuanchang in June and Fang Zhouzi in
August. Police took the relative and two accomplices into custody earlier
this month.
The bone of contention between Xiao and the Fangs is a surgical procedure
Xiao developed that he claimed can help patients with spinal cord injury and
spina bifida to restore some control over bladder and bowl movements. After
seeing material supporting Xiao's nomination as member of CAS in 2005, Fang
Zhouzi asserted on his Web site, New Threads, that Xiao's procedure was not
nearly as internationally famous as Xiao claimed and alleged that Xiao
exploited the Chinese public's inability to access information in English to
inflate his achievement. Xiao sued Fang for libel in a Wuhan court and won
in 2006, but attempts to sue Fang in Beijing courts failed.
Last December, while working for the Chinese biweekly Science News, Fang
Xuanchang edited a series of investigative reports on Xiao's procedure,
which has been performed on thousands of Chinese patients, according to Xiao
. Before the Ministry of Health in May 2009 issued regulations banning the
clinical application of unproven and controversial medical procedures such
as stem cell therapy, some Chinese hospitals peddled experimental procedures
to make more money. It's not clear whether Xiao's procedure falls in the
banned category, but no clinical trials have been conducted in China to
prove its efficacy. Many prospective patients were enticed by the touted 85%
success rate. Since publication of the investigative reports, however, "the
number of patients seeking treatment has fallen sharply," says Jia Hepeng,
editor-in-chief of Science News.
The procedure also caught the attention of Kenneth Peters, director of
urology research at the William Beaumont Hospital in Royal Oak, Michigan,
who launched a phase II clinical trial at his hospital (see also an
Associated Press report). Trial results have not been published. Peters also
obtained two grants from the National Institute of Health to study the
safety and efficacy of the procedure for treating spina bifida patients.
According to a description in his grant proposal, preliminary results show
that seven out of nine patients who received the treatment have shown
improvements. Peters did not respond to an e-mail request for comment.
Xiao could not be reached for comment. His employer, HUST, yesterday issued
an online statement that said the university was shocked by the police
investigation into Xiao's alleged crime of intentional injury to others. The
statement says that the university will follow the case closely and take
appropriate action once the judicial system renders its verdict.
Follow ScienceInsider on Facebook and Twitter
